Barry Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Sell
19,781
-71
-0.4% -$8.31K 0.53% 31
2026
Q1
$2.4M Sell
19,852
-2
-0% -$231 0.53% 32
2025
Q4
$2.09M Buy
19,854
+181
+0.9% +$17K 0.47% 36
2025
Q3
$1.65M Buy
19,673
+901
+5% +$74.2K 0.38% 43
2025
Q2
$1.5M Buy
18,772
+6,249
+50% +$497K 0.37% 44
2025
Q1
$1.13M Buy
12,523
+175
+1% +$16.3K 0.3% 46
2024
Q4
$1.24M Sell
12,348
-541
-4% -$55.8K 0.4% 40
2024
Q3
$1.46M Buy
12,889
+227
+2% +$27K 0.45% 37
2024
Q2
$1.58M Sell
12,662
-31
-0.2% -$3.99K 0.53% 34
2024
Q1
$1.68M Sell
12,693
-218
-2% -$26.9K 0.56% 35
2023
Q4
$1.42M Buy
12,911
+124
+1% +$12.9K 0.48% 38
2023
Q3
$1.33M Sell
12,787
-120
-0.9% -$12.9K 0.48% 41
2023
Q2
$1.5M Sell
12,907
-601
-4% -$68.2K 0.51% 38
2023
Q1
$1.45M Sell
13,508
-439
-3% -$47.4K 0.47% 39
2022
Q4
$1.55M Sell
13,947
-294
-2% -$30.1K 0.49% 38
2022
Q3
$1.24M Buy
14,241
+43
+0.3% +$3.84K 0.42% 41
2022
Q2
$1.3M Sell
14,198
-552
-4% -$48.9K 0.39% 43
2022
Q1
$1.22M Buy
14,750
+377
+3% +$29.7K 0.32% 48
2021
Q4
$1.11M Buy
14,373
+288
+2% +$22.9K 0.29% 50
2021
Q3
$1.07M Buy
14,085
+541
+4% +$41.1K 0.3% 47
2021
Q2
$1.06M Buy
13,544
+1,275
+10% +$94.8K 0.28% 47
2021
Q1
$909K Buy
12,269
+1,492
+14% +$110K 0.25% 53
2020
Q4
$847K Buy
10,777
+2,432
+29% +$186K 0.25% 43
2020
Q3
$665K Buy
8,345
+1,175
+16% +$92K 0.23% 41
2020
Q2
$531K Buy
+7,170
New +$540K 0.19% 46
2019
Q1
Sell
-106,385
Closed -$7.76M 78
2018
Q4
$7.76M Buy
106,385
+599
+0.6% +$42.3K 2.9% 13
2018
Q3
$7.16M Buy
105,786
+1,001
+1% +$63.8K 2.41% 19
2018
Q2
$6.07M Buy
104,785
+3,584
+4% +$202K 2.33% 19
2018
Q1
$5.26M Buy
101,201
+261
+0.3% +$14.1K 1.99% 19
2017
Q4
$5.42M Buy
100,940
+243
+0.2% +$13.5K 2.01% 18
2017
Q3
$6.15M Sell
100,697
-117
-0.1% -$7.09K 2.27% 17
2017
Q2
$6.17M Buy
100,814
+386
+0.4% +$23.5K 2.33% 17
2017
Q1
$6.09M Sell
100,428
-636
-0.6% -$38.6K 2.26% 18
2016
Q4
$5.68M Sell
101,064
-1,600
-2% -$93.6K 1.99% 20
2016
Q3
$6.11M Sell
102,664
-45,695
-31% -$2.67M 2.1% 19
2016
Q2
$8.15M Sell
148,359
-1,306
-0.9% -$69.5K 3.17% 12
2016
Q1
$7.56M Buy
149,665
+3,852
+3% +$189K 2.4% 14
2015
Q4
$7.35M Sell
145,813
-5,380
-4% -$271K 2.39% 15
2015
Q3
$7.13M Sell
151,193
-1,758
-1% -$93.4K 2.28% 15
2015
Q2
$8.31M Buy
152,951
+663
+0.4% +$37.2K 8.36% 6
2015
Q1
$8.35M Sell
152,288
-7,458
-5% -$422K 2.55% 14
2014
Q4
$8.66M Buy
+159,746
New +$8.9M 2.81% 12

Other funds holding MRK

Barry Investment Advisors's MRK Position: Q2 2026 in Review

Barry Investment Advisors reduced its Merck (MRK) stake by 0.36% in Q2 2026, selling an estimated $8.31K and leaving 19,781 shares worth $2.54M. The position accounts for 0.53% of the portfolio, ranked #31.

Barry Investment Advisors first reported a position in MRK in Q4 2014 and has held it in 42 quarters since. The position peaked at $8.66M in Q4 2014. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Barry Investment Advisors held 19,781 shares of Merck worth $2.54M as of Q2 2026.
  • Barry Investment Advisors sold 71 Merck shares in Q2 2026, an estimated $8.31K.
  • Merck made up 0.53% of Barry Investment Advisors's portfolio in Q2 2026, its #31 holding.
  • Barry Investment Advisors first reported a position in Merck in Q4 2014 and has held it in 42 quarters since.
  • Barry Investment Advisors's Merck position peaked at $8.66M in Q4 2014.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Barry Investment Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.